Leveraging AI to Enhance Operational Efficiency in Expanded Access Programs

• Addressing compliance considerations using AI to flag operational risks and red flags early in the process
• Leveraging data analytics to reshape programs around unmet medical needs, geographic distribution, and demographic insights to improve patient access
• Exploring AI applications for patient eligibility assessment, supply forecasting, and resource management

Speakers:

Laura Gagnon

Head, Global Oncology Early Access Programs

Takeda Pharmaceutical

David Rosolia

Global Senior Manager, Governance & Risk Management, MAP Global Operations

Sanofi